author-photo

Kosuke Egami

3

Papers

22

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile.

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (22)
Abstract A245: TAS-115, a novel potent dual MET/VEGFRs inhibitor, has highly safer profile leading to more potent efficacy in vivo.

2011 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Vehicle Dynamic Simulator

2006 The journal of the Institute of Electrical Engineers of Japan
Show All
- Source
- Cite
- Save
Citations (0)